Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 1.550
+0.100 (6.90%)
Jul 10, 2026, 10:50 AM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 1.88 billion as of July 9, 2026. Its market cap has increased by 469.06% in one year.
Market Cap
1.88B
Enterprise Value
1.58B
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 1.88B, a decrease of -87.48%. That is a compound annual growth rate of -35.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.88B | -38.02% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 2.77B |
| Antengene Corporation | 2.72B |
| Viva Biotech Holdings | 2.54B |
| Beijing Luzhu Biotechnology | 2.53B |
| HJ Science | 2.50B |
| TYK Medicines | 2.46B |
| PegBio | 2.22B |
| Frontage Holdings | 2.17B |